Business description: China Isotope & Radiation Corporation

China Isotope & Radiation Corp is a China-based company mainly engaged in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products. The Company operates five business segments. Pharmaceuticals segment is engaged in providing imaging diagnostic and therapeutic radiopharmaceuticals, urea breath test (UBT) kits and analyzers and in vitro diagnostic reagents and kits. Radioactive Source Products segment is engaged in providing various medical and industrial radioactive sources products as well as provision of related technical services. Irradiation segment is engaged in providing sterilization services. Radiation Therapy Equipment and Related Services segment is engaged in manufacturing Radiation therapy equipment. Other Businesses segment is engaged in providing trade services in relation to imported radioactive source, medical nuclides, imported radiopharmaceuticals, and other products.

Number of employees: 3,578

Sales by Activity: China Isotope & Radiation Corporation

Fiscal Period: December 2021 (CNY) 2022 (CNY) 2023 (CNY) 2024 (CNY) 2025 (CNY)

Nuclear Medicines

3.76B 3.93B 4.13B 4.17B 4.02B

Other Businesses

- - 816M 1.31B 1.6B

Independent Clinical Medical and Laboratory Services and Other Businesses (Excluding Radiation Therapy Equipments and Related Services)

338M 754M - - -

Radioactive Source Products

555M 618M 638M 746M 836M

Nuclear Medical Equipment and Related Services

404M 740M 941M 1.23B 602M

Irradiation

144M 165M 179M 200M 191M

Elimination of Inter-Segment

-52.36M -56.49M -71.1M -79.67M -62.82M

Geographical breakdown of sales: China Isotope & Radiation Corporation

Fiscal Period: December 2021 (CNY) 2022 (CNY) 2023 (CNY) 2024 (CNY) 2025 (CNY)

People's Republic of China (PRC)

5.14B 6.15B 6.63B 7.57B 7.19B

Executive Committee: China Isotope & Radiation Corporation

Manager TitleAgeSince
Corporate Secretary - 2024-08-29
Corporate Secretary - 2024-08-29
Comptroller/Controller/Auditor 52 2015-12-17

Composition of the Board of Directors: China Isotope & Radiation Corporation

Director TitleAgeSince
Director/Board Member 57 2017-02-21
Director/Board Member 54 2019-06-27
Director/Board Member 54 2019-12-29
Director/Board Member 57 2021-02-24
Director/Board Member 46 2021-02-24
Director/Board Member 46 2021-02-24
Director/Board Member 33 2022-08-29
Director/Board Member 36 2022-08-29
Director/Board Member 63 2023-06-29
Director/Board Member 58 2023-06-29

Shareholders: China Isotope & Radiation Corporation

NameStocks%Valuation
21.02 %
16,809,800 21.02 % 35 M $
11.14 %
8,906,400 11.14 % 18 M $
Serenity Capital Management Ltd. (Cayman Islands)
6.004 %
4,801,600 6.004 % 10 M $
UBS Asset Management Switzerland AG
4.787 %
3,828,322 4.787 % 8 M $
NameStocks%Valuation
China State-Owned Assets Supervision & Admn Commission
54.45 %
130,620,563 54.45 % 271 M $
China Institute of Atomic Energy Foundation
24.4 %
58,534,835 24.4 % 121 M $
Nuclear Power Institute of China
19.59 %
46,994,835 19.59 % 97 M $

Company details: China Isotope & Radiation Corporation

China Isotope & Radiation Corp.

No. 66

100045, Beijing

+86 10 6851 6810

http://www.china-isotope.com
address China Isotope & Radiation Corporation(1763)

Diagnostic & Testing Substances

Change 5-day change 1-year change 3-year change Capi.($)
-0.12%-1.66%-3.38%+30.55% 677M
+3.39%-0.31%+143.86%+369.61% 22.06B
-0.86%+0.94%-35.23%-21.60% 10.34B
-3.96%-7.32%+328.12%+10.97% 7.81B
-2.79%-11.53%-35.45% - 7B
-0.08%+0.01%+83.75%+49.90% 6.58B
+1.54%-1.38%-18.91%-19.92% 5.93B
-0.61%-0.37%-9.88%-21.77% 4.35B
-1.69%+5.43%+74.47%+86.82% 4.32B
+0.52%-3.16%-20.28%-27.66% 2.81B
Average -0.49%-1.85%+50.71%+50.77% 7.19B
Weighted average by Cap. +0.19%-1.96%+80.45%+130.23%
  1. Stock Market
  2. Stocks
  3. 1763 Stock
  4. Company China Isotope & Radiation Corporation